SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026-3
acquisitionAnnounced · Jan 18, 2026PharmaceuticalsSource · Community DiscussionsArticle · Expectations
Sun Pharma acquires Organon
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$10B
Target
Organon
NYSE: OGN · Jersey City, New Jersey
Acquirer
Sun Pharma
Full Acquisition
Status
Pending
Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-01-18. Figures and status may change as filings and press coverage update.
Strategic Rationale for the Organon Bid Sun Pharmaceutical Industries Ltd. , India largest pharmaceutical firm, is reportedly in advanced discussions to acquire U.S.-based Organon for a substantial $10 billion , inclusive of debt
Deal timeline
Announced
Jan 18, 2026 · whalesbook.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $10B. Figures and status may change as sources update.
Sources: whalesbook.com · Primary article · FireStrike proprietary index